What is a Medical Science Liaison in HealthTech?

A Medical Science Liaison (MSL) in HealthTech serves as the organisation's external-facing scientific and clinical authority for a product or portfolio. They're responsible for high-integrity medical engagement with clinicians, researchers, and other healthcare stakeholders, and for translating what's happening in real-world practice back into the company's decisions. In plain terms: an MSL exists so that the company's clinical story stays accurate, balanced, and useful to healthcare professionals, and so the product roadmap and evidence strategy stay anchored in patient impact rather than internal assumptions.

This role exists because HealthTech products often sit close to clinical decision-making, patient safety, and sensitive data. Those realities create a constant need for credible, non-sales scientific exchange, robust handling of medical questions, and disciplined interpretation of clinical evidence. The MSL owns the quality of those interactions: what is said externally, how questions are answered, how feedback is captured, and when issues must be escalated for safety, regulatory, or reputational reasons.

In most organisations, the MSL sits in Medical Affairs (or an equivalent clinical/scientific function), with clear separation from commercial targets. That independence is part of the job's accountability: to protect scientific credibility externally and to protect the company internally from "optimism drift" when evidence, adoption, or safety signals don't match the narrative.

🔍 How this role differs in HealthTech

In many tech sectors, strong customer relationships and product fluency are enough to guide adoption. In HealthTech, adoption is constrained by clinical risk, governance, and accountability structures that do not bend just because a product is usable or innovative. An MSL therefore operates in an environment where trust is earned through evidence quality, transparency about limitations, and consistent alignment with appropriate use, not through persuasion.

HealthTech also changes the "why" behind stakeholder conversations. The discussion is rarely only about features; it is about outcomes, clinical workflows, unintended consequences, and what happens when the product is used outside ideal conditions. Data sensitivity adds another layer: questions about model performance, bias, patient cohorts, interoperability, and information governance can quickly become clinical-safety questions, not just technical ones. The MSL is often the person expected to hold those threads together in a way that clinicians recognise as rigorous.

Finally, the pace versus risk trade-off is sharper. HealthTech teams may iterate quickly, but the MSL has to ensure the external scientific story doesn't get ahead of the evidence, that learning loops are structured, and that real-world feedback is channelled into decisions without compromising appropriate boundaries between scientific exchange and promotion.

🎯 Core responsibilities in HealthTech

Day to day, an MSL is accountable for being the organisation's credible scientific counterpart to external experts: building peer relationships, responding to nuanced medical questions, and ensuring discussions remain balanced and evidence-led even when the business is under pressure to grow. That means knowing the clinical context as well as the product: how care pathways actually run, what "good" looks like in outcomes, and where the product might introduce friction or risk.

In practice, the MSL constantly makes judgement calls under constraints. When an influential clinician challenges the evidence base, the MSL must decide what can be answered immediately, what requires escalation, and how to avoid over-claiming while still being helpful. When the field signals a mismatch between how the product was designed and how it's used in reality, the MSL must convert that into actionable insight for clinical, product, and leadership teams, without turning anecdote into "truth," and without diluting genuine safety or effectiveness concerns.

The role also involves steering internal trade-offs: supporting education and scientific understanding across the business while maintaining independence; enabling responsible adoption while protecting against inappropriate use; and helping prioritise evidence generation (clinical studies, real-world evaluation, publications) so that claims remain defensible and aligned to what healthcare stakeholders actually need.

🧩 Skills and competencies for HealthTech

Core Skill	HealthTech specific requirement	Reason or Impact
Scientific judgement	Ability to interpret clinical and real-world evidence with clear boundaries on what can and cannot be concluded	Prevents over-claiming, protects patient safety, and preserves external credibility when evidence is early, mixed, or context-dependent
Stakeholder trust-building	Peer-to-peer engagement style that works with clinicians, researchers, and governance stakeholders who are trained to challenge assumptions	Drives durable adoption based on confidence, not enthusiasm, and reduces reputational risk when scrutiny increases
Non-promotional communication discipline	Comfort holding a scientific line even when commercial urgency is high, including knowing when to escalate and when to decline	Maintains compliance and protects the organisation from blurred boundaries that can damage relationships and limit access
Systems thinking	Understanding how digital tools interact with clinical pathways, incentives, and operational constraints across sites	Improves the quality of field insights and helps teams avoid "local wins" that fail at scale or create downstream safety issues
Risk and issue escalation	Clear thresholds for when questions become safety, governance, or regulatory matters, and how to route them fast	Reduces time-to-mitigation and prevents small signals becoming high-impact incidents
Cross-functional influence	Ability to convert external insight into decisions across Product, Clinical, Quality, and Commercial without owning their line management	Ensures external reality changes internal priorities, especially when evidence work is hard, slow, or expensive

💷 Salary ranges in UK HealthTech

MSL pay in UK HealthTech is driven less by "years in role" alone and more by clinical and commercial criticality: the risk profile of the product, the maturity of the evidence base, the intensity of external scrutiny, and how much autonomy the MSL carries across a region or therapy area. Location still matters (London and the South East typically command a premium), but field coverage size, portfolio complexity, and stakeholder seniority can move compensation meaningfully. On-call expectations are not common for many MSL roles, but they can appear where rapid response to safety, incident, or high-stakes medical enquiries is expected.

Experience level	Estimated annual salary range	What drives compensation
Junior	London & South East: £45,000–£55,000 Rest of UK: £42,000–£52,000	Usually narrower portfolio, closer supervision, lower autonomy in external strategy; pay rises with stronger clinical credibility and independent handling of enquiries
Mid-level	London & South East: £55,000–£75,000 Rest of UK: £52,000–£70,000	Ownership of a territory and stakeholder plan, consistent insight quality, and ability to operate independently across evidence discussions and internal alignment
Senior	London & South East: £75,000–£90,000 Rest of UK: £70,000–£85,000	Higher-impact KOL networks, complex evidence conversations, greater influence on evidence strategy and cross-functional decisions; often broader coverage and higher scrutiny products
Lead	London & South East: £90,000–£110,000 Rest of UK: £85,000–£105,000	Leadership across a sub-team or programme, higher accountability for field medical standards, planning, and risk handling; may include national responsibilities or multi-product ownership
Head / Director	London & South East: £110,000–£150,000 Rest of UK: £105,000–£145,000	Strategic accountability for medical affairs outcomes, governance, external scientific reputation, and the operating model; compensation reflects organisational risk, scale, and leadership scope

Beyond base salary, total compensation commonly includes an annual bonus (often tied to company and functional objectives rather than sales), a car allowance (or company car) reflecting travel expectations, and broader benefits such as private healthcare and pension. Equity or long-term incentives show up more often in venture-backed HealthTech and later-stage scale-ups, especially for Lead and Head/Director roles. Variation is typically driven by portfolio risk, how "launch-critical" the role is, breadth of coverage, and whether the role is expected to respond rapidly to high-stakes medical or safety issues outside normal hours.

🚀 Career pathways

Common entry points into MSL roles include clinical or scientific careers where evidence interpretation and peer communication are central, such as nursing, pharmacy, life sciences, clinical research, or related medical affairs pathways. In HealthTech, candidates also enter from roles close to evidence generation and implementation, provided they can demonstrate strong scientific integrity and comfort working at the interface of product and clinical practice.

Progression tends to track ownership. Early on, responsibility is about handling enquiries accurately and building credible external relationships. As you grow, you own a territory strategy: which stakeholders matter, what insights the business needs, and how scientific engagement improves safe and appropriate use. Senior progression is less about being "more technical" and more about being trusted with higher-stakes products, messier evidence questions, and situations where the right answer is to slow down, add data, or change course.

Lead and Head/Director paths expand into operating model design: setting standards for scientific exchange, coaching other MSLs, shaping evidence strategy, and protecting organisational credibility when growth pressure conflicts with what the evidence supports.

❓ FAQ

Do HealthTech MSL interviews test technical product knowledge or clinical judgement?

Both, but judgement usually carries more weight. Expect scenario-based questions on how you would handle challenging evidence discussions, off-label-style enquiries (where relevant), and internal pressure to "simplify" the story. Strong candidates demonstrate boundaries, escalation instincts, and balanced communication.

How do I show I can be "non-promotional" if I'm coming from a commercial-facing role?

You'll need to demonstrate independence through examples: how you handled uncertainty, corrected misconceptions, or prioritised patient impact over persuasion. Hiring teams look for people who can build trust with clinicians by being transparent about limitations, not by "winning" the conversation.

Is on-call expected for a Medical Science Liaison in HealthTech?

It's not a universal requirement, but it can appear in roles tied to higher-risk products or where rapid response to medical enquiries is part of the operating model. If it's relevant, it should be clearly defined (frequency, boundaries, compensation approach) during the process. Ask directly so expectations are explicit.

🔎 Find your next role

If you're ready to build credibility at the intersection of evidence, product, and patient impact, search Medical Science Liaison roles on Meeveem.